<I>PLASMODIUM BERGHEI</I> : A STUDY ON LIVE TYPE VACCINE USING A PERMANENT ATTENUATED MUTANT
スポンサーリンク
概要
- 論文の詳細を見る
Extensive studies on malaria vaccine have been made to provide new technology for the control of the disease, which is still prevalent in the tropics. Genetic engineering to produce antigen epitope on malaria parasites raised new possibilities in this field, however, a vaccination model of long lasting effect still remains to be investigated. The present study was undertaken to propose a new malaria vaccine model using a rodent malaria system. An established strain, <I>Plasmodium</I> (<I>P</I>) <I>berghei</I> NK65XAT (XAT), is a permanent attenuated derivative of <I>P. berghei</I> NK65 (NK65). Only one parasite of the original NK65 inevitably kills one mouse, while, 10<SUP>7</SUP> XAT strain parasites caused a self-resolving type of low parasitemia in mice, and the mice remained apparently healthy. The mice inoculated with 10<SUP>6</SUP> XAT parasites showed a potent long-lasting resistance against challenge inoculation with 10<SUP>5</SUP> NK65 parasites of high virulence. Complete protection was shown by day 120 after immunization inoculation with XAT. Survival rates of 20-40% were recorded from day 180 to day 360 following the vaccination. The immunized mice were also completely resistant to challenge by a different strains of <I>P. berghei</I> ANKA. Immunity was also effective against challenge by different species of rodent <I>Plasmodia</I>, although 100% protection was not attained. Radical chemotherapy on mice inoculated with XAT did not reduce the immune effect. Hence, the resistance conferred on the immune mice was a different type of immunity from the classic premunition. It has been widely known that malaria causes some type of immune suppression in the host. However, so far as responsiveness of spleen cells to Con A, PHA, LPS and the parasite antigen concerned, suppression was not observed in mice immunized by XAT inoculation. These findings support the view that attenuated live type malaria vaccine could provide potent, long-lasting immunity without endangering the host.
- 北関東医学会の論文
北関東医学会 | 論文
- 12. PCTが行う緩和ケア外来―利根中央病院の経験―（第18回群馬緩和医療研究会）
- P-4.患者が「死にたい」とロにしたとき : 当院緩和ケアチームにおける精神科医の役割から見えたもの(パネルディスカッション,第15回群馬緩和医療研究会)
- 23.一般病棟でおこなう緩和ケア(心理的なケア)とは何か : いち臨床心理士から見えたもの(一般演題,第15回群馬緩和医療研究会)
- 19.医療者がケアの視点をもつことの意味(一般演題,第15回群馬緩和医療研究会)
- 11.終末期患者の食事摂取をめぐる倫理的葛藤(一般演題,第15回群馬緩和医療研究会)